绿叶制药股东将股票由建银国际证券转入UBS Securities Hong Kong Limited 转仓市值4.54亿港元

Group 1 - The core point of the article highlights the transfer of shares of Green Leaf Pharmaceutical (02186) from Jianyin International Securities to UBS Securities Hong Kong Limited, with a market value of HKD 454 million, representing 3.88% of the total shares [1] - Green Leaf Pharmaceutical announced a capital injection agreement on January 26, 2026, involving Shenzhen Green Leaf, Nanjing Xinshi, Nanjing Xinan, Ningbo Xinda, and Nanjing Green Leaf, with a total capital of RMB 285 million [1] - Following the completion of the capital injection, the ownership structure of Nanjing Green Leaf will be as follows: Shenzhen Green Leaf 70.01%, Nanjing Xinshi 23.34%, Nanjing Xinan 4.32%, and Ningbo Xinda 2.33% [1]